93 7220 Pill - pink capsule-shape, 14mm
Pill with imprint 93 7220 is Pink, Capsule-shape and has been identified as Topiramate 200 mg. It is supplied by Teva Pharmaceuticals USA.
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizures; migraine prevention; seizure prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7220



Topiramate
- Imprint
- 93 7220
- Strength
- 200 mg
- Color
- Pink
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide,
hypromellose 2910 (15 mPa.s),
polydextrose,
ferric oxide red,
FD&C Red No. 40,
aluminum oxide,
FD&C Blue No. 2,
indigotindisulfonate sodium
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00093-7220 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
68071-0181 | Nucare Pharmaceuticals Inc. (repackager) |
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,305)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Drug Information
- Topiramate (Advanced Reading)
- Topiramate Extended-Release Capsules
- Topiramate Tablets
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.